Cart
sales@molnova.com
LysoFos Choline 12
CAS No. 20559-18-6
LysoFos Choline 12( —— )
Catalog No. M37721 CAS No. 20559-18-6
LysoFos Choline 12 (1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine) is an amphoteric surfactant that acts as a biofilm mimic for self-aggregation in aqueous solution.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 42 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 136 | In Stock |
|
| 50MG | 212 | In Stock |
|
| 100MG | 318 | In Stock |
|
| 200MG | 462 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLysoFos Choline 12
-
NoteResearch use only, not for human use.
-
Brief DescriptionLysoFos Choline 12 (1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine) is an amphoteric surfactant that acts as a biofilm mimic for self-aggregation in aqueous solution.
-
DescriptionLysoFos Choline 12 (1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine) is an amphoteric surfactant that acts as a biofilm mimic for self-aggregation in aqueous solution.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number20559-18-6
-
Formula Weight439.52
-
Molecular FormulaC20H42NO7P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESP(OC[C@@H](COC(CCCCCCCCCCC)=O)O)(OCC[N+](C)(C)C)(=O)[O-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Citronellyl Propiona...
Citronellyl propionate is a RIFM fragrance from the bark of citrus trees. It is a potential insect repellent and has a strong repellent effect on castor caterpillars.
-
Elopiprazole
Elopiprazole(DU 29840) is an anti-neurological compound that can be used to study neurological disorders.
-
Porcine dynorphin A(...
Porcine dynorphin A (1-13) is a potent, endogenous κ opioid receptor agonist and is antinociceptive at physiological concentrations. Exposure to dynorphin A (1-13) causes acute increases in [Ca2+]i in individual neurons similar to increases seen with acute NMDA treatment.
